In this study, we aimed to examine whether low ADAMTS13 antigen level before rt-PA treatment (1) could predict functional outcomes 90 days after stroke; (2) could predict hemorrhagic transformation; (3) was associated with poor collateral flow in a subset of AIS patients with large vessel occlusion. This evidence concerns the gene ADAMTS13 and stroke disorder.